Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iren (IREN) Total Liabilities (2020 - 2025)

Iren (IREN) has disclosed Total Liabilities for 6 consecutive years, with $4.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 462.57% to $4.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.5 billion, a 462.57% increase, with the full-year FY2025 number at $1.1 billion, up 1928.76% from a year prior.
  • Total Liabilities was $4.5 billion for Q4 2025 at Iren, up from $1.4 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $4.5 billion in Q4 2025 to a low of -$1.2 billion in Q4 2024.
  • A 5-year average of $561.6 million and a median of $133.1 million in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 6575.93% in 2021, then plummeted 79.93% in 2023.
  • Iren's Total Liabilities stood at $183.9 million in 2021, then decreased by 27.63% to $133.1 million in 2022, then tumbled by 79.93% to $26.7 million in 2023, then plummeted by 4763.07% to -$1.2 billion in 2024, then skyrocketed by 462.57% to $4.5 billion in 2025.
  • Per Business Quant, the three most recent readings for IREN's Total Liabilities are $4.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.1 billion (Q2 2025).